Aspen Neuroscience, Inc. (ASPE) stock analysis
ASPEPharmaceutical PreparationsFiscal year ends December 31
$14.89+14.88 (+148800.00%)
Close on Oct 30, 2026Market cap –P/E –Yield –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Aspen Neuroscience.